SOPHSOPHiA GENETICS S.A.

$308M

Q1 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$16M+13.0% YoY

Gross Profit

$10M65.9% margin

Operating Income

-$19M-118.9% margin

Net Income

-$14M-86.8% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

-7.4%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$17M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$180M

Total Liabilities

$48M

Stockholders' Equity

$132M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$14M	+13.0%
Gross Profit	$10M	$10M	+7.3%
Operating Income	-$19M	-$19M	+2.8%
Net Income	-$14M	-$20M	+30.4%

SOPH Q1 2024 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena